Sign Up to like & get
recommendations!
1
Published in 2022 at "Pharmaceuticals"
DOI: 10.3390/ph15070855
Abstract: NAPRT, the rate-limiting enzyme of the Preiss–Handler NAD biosynthetic pathway, has emerged as a key biomarker for the clinical success of NAMPT inhibitors in cancer treatment. Previous studies found that high protein levels of NAPRT…
read more here.
Keywords:
biological characterization;
structure;
naprt inhibitors;
based identification ... See more keywords